114 related articles for article (PubMed ID: 2696398)
1. [Antinuclear and anticytoplasmic antibodies in 24 cases of dermatomyositis. Value of western blotting].
Meyer O; Aeschlimann A; Bourgeois P; Belmatoug N; Palazzo E; Haim T; Kahn MF
Ann Med Interne (Paris); 1989; 140(6):449-52. PubMed ID: 2696398
[TBL] [Abstract][Full Text] [Related]
2. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
[TBL] [Abstract][Full Text] [Related]
3. [The principle antinuclear and anti-cytoplasmic antibodies in polymyositis and dermatomyositis. Study of 42 cases].
Meyer O; Cremer-Legmann F; Haim T; Ryckewaert A
Presse Med; 1987 Feb; 16(4):155-8. PubMed ID: 2950445
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of anticytoplasmic antibodies found on fluorescent antinuclear antibody testing.
Tesser JR; Rothberger H; Agudelo C
J Rheumatol; 1983 Apr; 10(2):227-34. PubMed ID: 6345769
[TBL] [Abstract][Full Text] [Related]
5. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
Yamagata H; Akizuki M; Tojo T; Homma M
Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
[TBL] [Abstract][Full Text] [Related]
6. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
[TBL] [Abstract][Full Text] [Related]
7. [Cytoplasmic staining pattern characteristic for anti Jo-1 antibody in HEp-2 cells].
Nagano Y; Yoshinoya S; Ohkubo A
Rinsho Byori; 1991 Mar; 39(3):269-72. PubMed ID: 1711130
[TBL] [Abstract][Full Text] [Related]
8. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
[TBL] [Abstract][Full Text] [Related]
9. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
[TBL] [Abstract][Full Text] [Related]
11. Spectrum and clinical significance of autoantibodies against transfer RNA.
Ohosone Y; Ishida M; Takahashi Y; Matsumura M; Hirakata M; Kawahara Y; Nishikawa T; Mimori T
Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095
[TBL] [Abstract][Full Text] [Related]
12. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma.
Thomas PJ; Kaur JS; Aitcheson CT; Robinson WA; Tan EM
Cancer Res; 1983 Mar; 43(3):1372-80. PubMed ID: 6337706
[TBL] [Abstract][Full Text] [Related]
13. [Antinuclear and anticytoplasmic antibodies in polymyositis and dermatomyositis].
Nishikai M; Sugimoto M; Sato A
Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1597-601. PubMed ID: 3493313
[No Abstract] [Full Text] [Related]
14. [Antinuclear antibodies in rheumatology].
Zuber M
Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
[TBL] [Abstract][Full Text] [Related]
15. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
[TBL] [Abstract][Full Text] [Related]
16. [Determination of autoimmune antibodies using Western blot technique in the routine laboratory. Problems with determining and comparing three test kits].
Bauerfeind S; Heide KG
Z Rheumatol; 1994; 53(2):66-71. PubMed ID: 8023587
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of circulating autoantibodies in healthy individuals].
Teubner A; Tillmann HL; Schuppan D; Gericke G; Manns MP; Stölzel U
Med Klin (Munich); 2002 Nov; 97(11):645-9. PubMed ID: 12434272
[TBL] [Abstract][Full Text] [Related]
19. Immunoserological aspects of idiopathic inflammatory muscle disease.
Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T
Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
